Related Content
The FoxCross PTA Catheter is a next-generation .035 balloon dilatation catheter is used to open peripheral arteries that ...
September 3, 2009 โ Abbott said last week it received approval from Health Canada for the XIENCE V Everolimus-Eluting ...
September 2, 2009 โ Abbott announced Monday at the European Society of Cardiology Congress the widespread availability ...
August 13, 2009 โ Abbott today announced the expansion of the company's XIENCE V USA post-approval study designed to ...
August 13, 2009 โ The pharmaceutical and healthcare research firm Decision Resources found Merck/Schering-Plough's Zetia ...
August 3, 2009 โ Abbott is conducting a voluntary recall of its POWERSAIL Coronary Dilatation Catheters, which may be ...
July 29, 2009 โ Medtronic Inc. said earlier this week it has reached a settlement with Abbott Laboratories over ...
When stenting emerged as a minimally- invasive treatment for clogged arteries associated with peripheral artery disease ...
There has been a growing trend in electrophysiology toward remote, home monitoring of implantable cardioverter ...
June 23, 2009 โ Abbott said today it received CE mark (Conformite Europeenne) for its next-generation Xience PRIME ...